Cargando…
The Utility of Oral Vitamin B1 and Mecobalamin to Improve Corneal Nerves in Dry Eye Disease: An In Vivo Confocal Microscopy Study
Our purpose is to demonstrate the changes in cornea nerve parameters and symptoms and signs in dry eye disease (DED) patients after oral vitamin B1 and mecobalamin treatment. In this randomized double-blind controlled trial, DED patients were randomly assigned to either the treatment group (oral vit...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504679/ https://www.ncbi.nlm.nih.gov/pubmed/36145126 http://dx.doi.org/10.3390/nu14183750 |
_version_ | 1784796277450473472 |
---|---|
author | Ren, Xiaotong Chou, Yilin Wang, Yuexin Jing, Dalan Chen, Yanyan Li, Xuemin |
author_facet | Ren, Xiaotong Chou, Yilin Wang, Yuexin Jing, Dalan Chen, Yanyan Li, Xuemin |
author_sort | Ren, Xiaotong |
collection | PubMed |
description | Our purpose is to demonstrate the changes in cornea nerve parameters and symptoms and signs in dry eye disease (DED) patients after oral vitamin B1 and mecobalamin treatment. In this randomized double-blind controlled trial, DED patients were randomly assigned to either the treatment group (oral vitamin B1 and mecobalamin, artificial tears) or the control group (artificial tears). Corneal nerve parameters via in vivo confocal microscopy (IVCM), DED symptoms, and signs were assessed at baseline and 1 and 3 months post-treatment. In total, 398 eyes from 199 patients were included. In the treatment group, there were significant improvements in corneal nerve length, width, and neuromas, the sign of conjunctival congestion score (CCS), symptoms of dryness, pain, photophobia, blurred vision, total symptom score, and OSDI (OSDI) at 1/3 months post-treatment (all p < 0.05). Patients who received vitamin B1 and mecobalamin showed greater improvement in CCS, dryness scores at 1 month (p < 0.05), corneal fluorescein staining (CFS) (p = 0.012), photophobia (p = 0.032), total symptom scores (p = 0.041), and OSDI (p = 0.029) at 3 months. Greater continuous improvement in CFS (p = 0.045), dryness (p = 0.033), blurred vision (p = 0.031) and total symptom scores (p = 0.023) was demonstrated at 3 months than at 1 month post-treatment in the treatment group. We found that oral vitamin B1 and mecobalamin can improve corneal nerve length, width, reflectivity and the number of neuromas in IVCM, thereby repairing epithelial cells and alleviating some ocular symptoms. Thus, vitamin B1 and mecobalamin are potential treatment options for patients with DED. |
format | Online Article Text |
id | pubmed-9504679 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95046792022-09-24 The Utility of Oral Vitamin B1 and Mecobalamin to Improve Corneal Nerves in Dry Eye Disease: An In Vivo Confocal Microscopy Study Ren, Xiaotong Chou, Yilin Wang, Yuexin Jing, Dalan Chen, Yanyan Li, Xuemin Nutrients Article Our purpose is to demonstrate the changes in cornea nerve parameters and symptoms and signs in dry eye disease (DED) patients after oral vitamin B1 and mecobalamin treatment. In this randomized double-blind controlled trial, DED patients were randomly assigned to either the treatment group (oral vitamin B1 and mecobalamin, artificial tears) or the control group (artificial tears). Corneal nerve parameters via in vivo confocal microscopy (IVCM), DED symptoms, and signs were assessed at baseline and 1 and 3 months post-treatment. In total, 398 eyes from 199 patients were included. In the treatment group, there were significant improvements in corneal nerve length, width, and neuromas, the sign of conjunctival congestion score (CCS), symptoms of dryness, pain, photophobia, blurred vision, total symptom score, and OSDI (OSDI) at 1/3 months post-treatment (all p < 0.05). Patients who received vitamin B1 and mecobalamin showed greater improvement in CCS, dryness scores at 1 month (p < 0.05), corneal fluorescein staining (CFS) (p = 0.012), photophobia (p = 0.032), total symptom scores (p = 0.041), and OSDI (p = 0.029) at 3 months. Greater continuous improvement in CFS (p = 0.045), dryness (p = 0.033), blurred vision (p = 0.031) and total symptom scores (p = 0.023) was demonstrated at 3 months than at 1 month post-treatment in the treatment group. We found that oral vitamin B1 and mecobalamin can improve corneal nerve length, width, reflectivity and the number of neuromas in IVCM, thereby repairing epithelial cells and alleviating some ocular symptoms. Thus, vitamin B1 and mecobalamin are potential treatment options for patients with DED. MDPI 2022-09-11 /pmc/articles/PMC9504679/ /pubmed/36145126 http://dx.doi.org/10.3390/nu14183750 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ren, Xiaotong Chou, Yilin Wang, Yuexin Jing, Dalan Chen, Yanyan Li, Xuemin The Utility of Oral Vitamin B1 and Mecobalamin to Improve Corneal Nerves in Dry Eye Disease: An In Vivo Confocal Microscopy Study |
title | The Utility of Oral Vitamin B1 and Mecobalamin to Improve Corneal Nerves in Dry Eye Disease: An In Vivo Confocal Microscopy Study |
title_full | The Utility of Oral Vitamin B1 and Mecobalamin to Improve Corneal Nerves in Dry Eye Disease: An In Vivo Confocal Microscopy Study |
title_fullStr | The Utility of Oral Vitamin B1 and Mecobalamin to Improve Corneal Nerves in Dry Eye Disease: An In Vivo Confocal Microscopy Study |
title_full_unstemmed | The Utility of Oral Vitamin B1 and Mecobalamin to Improve Corneal Nerves in Dry Eye Disease: An In Vivo Confocal Microscopy Study |
title_short | The Utility of Oral Vitamin B1 and Mecobalamin to Improve Corneal Nerves in Dry Eye Disease: An In Vivo Confocal Microscopy Study |
title_sort | utility of oral vitamin b1 and mecobalamin to improve corneal nerves in dry eye disease: an in vivo confocal microscopy study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504679/ https://www.ncbi.nlm.nih.gov/pubmed/36145126 http://dx.doi.org/10.3390/nu14183750 |
work_keys_str_mv | AT renxiaotong theutilityoforalvitaminb1andmecobalamintoimprovecornealnervesindryeyediseaseaninvivoconfocalmicroscopystudy AT chouyilin theutilityoforalvitaminb1andmecobalamintoimprovecornealnervesindryeyediseaseaninvivoconfocalmicroscopystudy AT wangyuexin theutilityoforalvitaminb1andmecobalamintoimprovecornealnervesindryeyediseaseaninvivoconfocalmicroscopystudy AT jingdalan theutilityoforalvitaminb1andmecobalamintoimprovecornealnervesindryeyediseaseaninvivoconfocalmicroscopystudy AT chenyanyan theutilityoforalvitaminb1andmecobalamintoimprovecornealnervesindryeyediseaseaninvivoconfocalmicroscopystudy AT lixuemin theutilityoforalvitaminb1andmecobalamintoimprovecornealnervesindryeyediseaseaninvivoconfocalmicroscopystudy AT renxiaotong utilityoforalvitaminb1andmecobalamintoimprovecornealnervesindryeyediseaseaninvivoconfocalmicroscopystudy AT chouyilin utilityoforalvitaminb1andmecobalamintoimprovecornealnervesindryeyediseaseaninvivoconfocalmicroscopystudy AT wangyuexin utilityoforalvitaminb1andmecobalamintoimprovecornealnervesindryeyediseaseaninvivoconfocalmicroscopystudy AT jingdalan utilityoforalvitaminb1andmecobalamintoimprovecornealnervesindryeyediseaseaninvivoconfocalmicroscopystudy AT chenyanyan utilityoforalvitaminb1andmecobalamintoimprovecornealnervesindryeyediseaseaninvivoconfocalmicroscopystudy AT lixuemin utilityoforalvitaminb1andmecobalamintoimprovecornealnervesindryeyediseaseaninvivoconfocalmicroscopystudy |